The revised EU Detergents Regulation (Regulation (EU) 2026/405) has recently been published and represents an important development in the European regulatory framework governing cleaning products. As innovation continues to drive the adoption of biotechnology in the detergents sector, the regulation introduces new provisions that will shape how ingredients are assessed and regulated in the future.
Genesis Biosciences has closely followed the development of the revised EU Detergents Regulation and remains committed to supporting customers with clear guidance as the regulatory landscape evolves.
What Is the EU Detergents Regulation?
The EU Detergents Regulation (EU) 2026/405 is the updated legislative framework governing the safety, composition, labelling, and environmental impact of detergent products placed on the European market.
The revised regulation aims to modernise the existing regulatory structure to reflect advances in cleaning technologies, including the growing use of microbial and enzyme-based formulations.
When Will the EU Detergents Regulation Apply?
The revised EU Detergents Regulation will follow a staged implementation timeline.
- The regulation will enter into force on 22 March 2026
- The provisions within the regulation will become applicable on 23 September 2029.
This extended transition period allows manufacturers, regulators and stakeholders sufficient time to prepare for the new regulatory framework.
During this transition phase, the detergents sector will continue operating under existing requirements while additional implementation guidance is developed.
How the EU Detergents Regulation Addresses Microorganisms
One of the most significant developments in the revised EU Detergents Regulation is the introduction of a dedicated risk assessment framework for microorganisms used in detergent formulations.
This framework will be established through a delegated act under Article 30(6), which will define the methodology for evaluating the safety of microbial ingredients.
At present, this Article 30(6) delegated act has not yet been published. As a result, the specific provisions relating to microorganisms are not currently operational.
Until the microbial risk assessment methodology is finalised and implemented, microbial-based cleaning products already placed on the market are not subject to the new provisions introduced by the revised regulation.
Genesis Biosciences’ Engagement with the EU Detergents Regulation
Genesis Biosciences has actively followed the development of the revised EU Detergents Regulation throughout the legislative process.
During this period, the company has contributed:
- Scientific expertise relating to microbial technologies
- Industry insights to support practical regulatory approaches
- Engagement with regulatory stakeholders
This involvement reflects Genesis Biosciences’ commitment to ensuring that emerging regulatory frameworks remain science-based, proportionate, and supportive of innovation within the cleaning products sector.
Alignment of EVOGEN® and EVOZYME® Technologies
Although the microbial risk assessment framework under Article 30(6)is still pending, Genesis Biosciences has reviewed the direction of the revised regulations and assessed its technology portfolio against anticipated regulatory expectations.
Based on this review, the EVOGEN® and EVOZYME® grades within the Genesis Biosciences portfolio are aligned with the expected regulatory approach.
The Bacillus strains intentionally incorporated into these microbial cleaning technologies meet several key characteristics:
- They are non-genetically modified organisms (non-GMO)
- They are deposited with recognised international culture collections
- Each strain is identified at strain level
- Identification is confirmed through whole genome sequencing (WGS)
- Strains are managed within Genesis Biosciences’ internal quality management system
These practices ensure that microbial components used in Genesis Biosciences formulations are well characterised, traceable, and consistently controlled.
Quality and Safety Controls for Microbial Cleaning Technologies
As part of its established safety and quality framework, Genesis Biosciences routinely applies rigorous scientific controls to its microbial ingredients.
These measures include:
- Verification of strain identity and purity
- Confirmation of the absence of relevant pathogens
- Generation of antibiotic susceptibility profiles using EUCAST methodology (excluding intrinsic resistance)
- Maintenance of defined shelf-life specifications and CFU thresholds within internal quality systems
This structured approach ensures that microbial ingredients used in cleaning products remain safe, consistent, and well characterised.
Preparing for Full Implementation of the EU Detergents Regulation
Before the revised EU Detergents Regulation becomes fully applicable in 2029 and as soon as the implementing methodologies, particularly the Article 30 (6) microbial risk assessment framework, are published, Genesis Biosciences will conduct a structured regulatory gap assessment.
This process will allow the company to:
- Review final technical requirements in detail
- Confirm full alignment across relevant product ranges
- Update documentation and compliance processes where necessary
Genesis Biosciences remains committed to maintaining high standards of regulatory compliance, product safety and transparency as the regulatory environment continues to evolve.
What the EU Detergents Regulation Means for Customers Today
At this stage, no additional regulatory action is required for microbial cleaning products currently placed on the market.
The revised regulation remains within its transition period, and key implementation measures are still under development.
Genesis Biosciences will continue to monitor regulatory updates and provide customers with clear guidance as further details become available.
Key Takeaways
- The EU Detergents Regulation (EU) 2026/405 will enter into force on 22 March 2026
- Its requirements will become applicable from 23 September 2029
- A delegated act under Article 30 (6) will define the microbial risk assessment methodology
- Microbial cleaning products currently on the market are not yet subject to the new provisions
- Genesis Biosciences’ EVOGEN® and EVOZYME® technologies are aligned with the anticipated regulatory framework